Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-24 @ 5:25 PM
NCT ID:
NCT06819150
Eligibility Criteria:
Inclusion Criteria:
* Born at 35-41 gestational weeks
* Indirect hyperbilirubinaemia diagnosed at 24 hours of birth or more,
* No health problems,
* Indication for phototherapy treatment
* Stable vital signs
* Whose parents agreed to participate in the study
Exclusion Criteria:
* Newborns with ABO and Rh incompatibility,
* Direct diagnosis of hyperbilirubinaemia,
* Congenital anomaly,
* With skin lesions
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Day
Maximum Age:
28 Days
Study:
NCT06819150
Study Brief:
Protocol Section:
NCT06819150